Jim Wood currently serves as the West Regional Business Director at Pharming Healthcare, Inc., where he leverages over 32 years of extensive experience in pharmaceutical and biotech sales. His role is pivotal in leading and supporting a dedicated team of eight Ruconest Account Managers across...
Jim Wood currently serves as the West Regional Business Director at Pharming Healthcare, Inc., where he leverages over 32 years of extensive experience in pharmaceutical and biotech sales. His role is pivotal in leading and supporting a dedicated team of eight Ruconest Account Managers across four key territories in the western United States, including the Midwest, Rockies, Southern California, and the Pacific Northwest. Jim’s expertise spans a diverse range of therapeutic areas, including Bone Marrow Transplantation (BMT), Organ Transplantation, Infectious Diseases, Neonatology, Neurology, and Rare Genetic Disorders, making him a valuable asset in navigating the complexities of these specialized markets.
At Pharming, Jim is currently focused on driving the successful adoption and utilization of Ruconest, a critical therapy for patients with Hereditary Angioedema. His strategic vision and leadership are instrumental in executing targeted sales initiatives and fostering strong relationships with healthcare providers and stakeholders. Jim’s proven track record includes successfully launching four novel products during his career, underscoring his capability to navigate the challenges of product introduction in competitive environments.
With a passion for advancing patient care, Jim aims to continue his journey in launching innovative therapies with start-up organizations, where he can apply his extensive knowledge in managed care and product launch strategies. His commitment to excellence in pharmaceutical sales, combined with his deep understanding of various medical specialties, positions him as a key player in the ongoing evolution of healthcare solutions.
